TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Blood glucose consumables and EQA materials

Blood-testing reagents
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Wales Shared Services Partnership - Procurement Services: "Blood glucose consumables and EQA materials". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS Wales Shared Services Partnership - Procurement ServicesScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS Wales Shared Services Partnership - Procurement Services
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS Wales Shared Services Partnership - Procurement Services. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 1 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published22 Oct 2021, 12:45 BST
Last source update22 Oct 2021, 12:45 BST
Recurring procurementNot published
ClassificationBlood-testing reagents
Delivery area
OCIDocds-h6vhtk-02ef02
What is being bought
Supply of blood glucose consumables (testing strips) and EQA materials.
What changed
From the official release history
  1. Status changed to complete
    22 Oct 2021, 12:45 BST
  2. Official notice release published
    22 Oct 2021, 12:45 BST
  3. Buyer information updated
    22 Oct 2021, 12:45 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    Status not published
    Published valueNot published
    Blood glucose monitoring refers to testing the concentration of glucose in the blood to aid the management of Diabetes types 1 & 2. Similarly, monitoring the presence of ketones in the blood is also important as high levels can result in complications such as Ketoacidosis. This procurement will involve the supply of Blood glucose monitoring equipment(meters) and associated consumables (Test-strips for the Point of Care Testing Service at Cwm Taf Morgannwg University Health Board. This will be to renew the existing arrangement with Abbott Laboratories Ltd.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    22 Oct 2021, 12:45 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 8 Oct 2021, 00:00 BST · £237,488
Commercial outcome and competition
Awards
Abbott Laboratories Ltd
Not published · Not published · active
Contracts
Contract
£237,488 · signed 8 Oct 2021, 00:00 BST · active
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

NHS Wales Shared Services Partnership - Procurement Services

Contracting authority GB-FTS-32563
View buyer profile
  • NHS Wales Shared Services Partnership - Procurement Services
    buyer

    4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw, Cardiff, UK, CF47 9DT
    +44 1443848585
  • Abbott Laboratories Ltd
    supplier

    Abbott House, Vanwall Business Park, Maidenhead, UK, SL64XE
  • High Court
    reviewBody

    Royal Courts of Justice, The Strand, London, WC2A 2LL
    +44 2079477501
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThe current contract with Abbott Laboratories Ltd ended on the 30th of September 2021. The Health Board's intention was to enter into a new contract with Abbott Laboratories Ltd through a direct award under the terms of a Public Sector Framework. This would enable sufficient time for NWSSP Shared Services Procurement to undertake a formal market-test exercise, to award a new All Wales Framework. Currently, the Health Board's POCT Service is not able to contemplate an alternative supplier for the reasons outlined below: The migration of operators to a completely new device would need to be completed on a rolling basis with full training for every member of staff. The POCT Team is not in a position to support this due to the extra training demands in relation to Covid-19 and the clinical areas are still finding it difficult to release staff to attend training, due to staffing pressures. The current management of testing allows for staff to move flexibly from one area or site to another. During the process of migration, this flexibility will be lost to a degree with some areas using the new meter and other areas using the existing meter, this could expose the HB to risk, given current staffing pressures. The Health Board cannot find a Public Sector Framework with which to engage with Abbott Laboratories Ltd at this time and therefore, there is no opportunity to make a compliant direct award. For the reasons outlined above and to ensure continuity of service for patient care, the Health Board has no option but to enter into a 12-month agreement without any formal underpinning Framework arrangement.